335 related articles for article (PubMed ID: 9365197)
1. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
2. 7alpha-Arylaliphatic androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
O'Reilly JM; Brueggemeier RW
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):93-102. PubMed ID: 9009242
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibition in JAr choriocarcinoma cells by 7alpha-arylaliphatic androgens.
Brueggemeier RW; Gilbert NE; Gu X; O'Reilly JM; Lovely CJ
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):73-7. PubMed ID: 9328212
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
O'Reilly JM; Li N; Duax WL; Brueggemeier RW
J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
[TBL] [Abstract][Full Text] [Related]
5. Substituted C19 steroid analogs as inhibitors of aromatase.
Brueggemeier RW; Snider CE; Counsell RE
Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
[TBL] [Abstract][Full Text] [Related]
6. 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
Akkani A; Paterlini G; Gleason WB; Ojala WH; Abul-Hajj YJ
J Med Chem; 1997 Sep; 40(20):3263-70. PubMed ID: 9379446
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
Ebrahimian S; Chen HH; Brueggemeier RW
Steroids; 1993 Sep; 58(9):414-22. PubMed ID: 8236327
[TBL] [Abstract][Full Text] [Related]
8. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
Takahashi M; Yamashita K; Numazawa M
Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures.
Brueggemeier RW; Katlic NE
Cancer Res; 1990 Jun; 50(12):3652-6. PubMed ID: 2340513
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological development of steroidal inhibitors of aromatase.
Brueggemeier RW; Li PK; Chen HH; Moh PP; Katlic NE
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):379-85. PubMed ID: 2257241
[TBL] [Abstract][Full Text] [Related]
12. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
Numazawa M; Shelangouski M; Nagasaka M
Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
[TBL] [Abstract][Full Text] [Related]
13. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
Brueggemeier RW; Li PK
Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
[TBL] [Abstract][Full Text] [Related]
14. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
[TBL] [Abstract][Full Text] [Related]
17. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
Brueggemeier RW; Katlic NE
Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of a new family of steroidal aromatase inhibitors. 1. Synthesis and evaluation of a series of analogs related to 19-[(methylthio)methyl]androstenedione (RU54115).
Lesuisse D; Gourvest JF; Benslimane O; Canu F; Delaisi C; Doucet B; Hartmann C; Lefrançois JM; Tric B; Mansuy D; Philibert D; Teutsch G
J Med Chem; 1996 Feb; 39(3):757-72. PubMed ID: 8576919
[TBL] [Abstract][Full Text] [Related]
20. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
Numazawa M; Yoshimura A; Oshibe M
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
